Drugs pact will see firms sharing data on Alzheimer's, lupus

A pact brokered by the U.S. National Institutes of Health will see a group of pharmaceutical companies and non-profit organizations co-operating in the race to find drugs to treat Alzheimer’s disease, Type 2 diabetes, rheumatoid arthritis and lupus.

Read the whole article on CBC: Health

More from CBC: Health